These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8524140)

  • 1. Use of yeast for identification of farnesyltransferase inhibitors and for generation of mutant farnesyltransferases.
    Tamanoi F; Mitsuzawa H
    Methods Enzymol; 1995; 255():82-91. PubMed ID: 8524140
    [No Abstract]   [Full Text] [Related]  

  • 2. RAM2, an essential gene of yeast, and RAM1 encode the two polypeptide components of the farnesyltransferase that prenylates a-factor and Ras proteins.
    He B; Chen P; Chen SY; Vancura KL; Michaelis S; Powers S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11373-7. PubMed ID: 1763050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras farnesyltransferase: a new therapeutic target.
    Leonard DM
    J Med Chem; 1997 Sep; 40(19):2971-90. PubMed ID: 9301658
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutational analysis of the beta-subunit of yeast geranylgeranyl transferase I.
    Ohya Y; Caplin BE; Qadota H; Tibbetts MF; Anraku Y; Pringle JR; Marshall MS
    Mol Gen Genet; 1996 Aug; 252(1-2):1-10. PubMed ID: 8804398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of yeast type-II geranylgeranyltransferase.
    Jiang Y; Rossi G; Ferro-Novick S
    Methods Enzymol; 1995; 257():21-9. PubMed ID: 8583924
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo assays for farnesyltransferase inhibitors with Saccharomyces cerevisiae.
    Mitsuzawa H; Tamanoi F
    Methods Enzymol; 1995; 250():43-51. PubMed ID: 7651169
    [No Abstract]   [Full Text] [Related]  

  • 7. CDC43 and RAM2 encode the polypeptide subunits of a yeast type I protein geranylgeranyltransferase.
    Mayer ML; Caplin BE; Marshall MS
    J Biol Chem; 1992 Oct; 267(29):20589-93. PubMed ID: 1400380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein geranylgeranyltransferase of Saccharomyces cerevisiae is specific for Cys-Xaa-Xaa-Leu motif proteins and requires the CDC43 gene product but not the DPR1 gene product.
    Finegold AA; Johnson DI; Farnsworth CC; Gelb MH; Judd SR; Glomset JA; Tamanoi F
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4448-52. PubMed ID: 2034682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoaffinity labeling of yeast farnesyl protein transferase and enzymatic synthesis of a Ras protein incorporating a photoactive isoprenoid.
    Edelstein RL; Distefano MD
    Biochem Biophys Res Commun; 1997 Jun; 235(2):377-82. PubMed ID: 9199201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesylation and proteolysis are sequential, but distinct steps in the CaaX box modification pathway.
    Farh L; Mitchell DA; Deschenes RJ
    Arch Biochem Biophys; 1995 Apr; 318(1):113-21. PubMed ID: 7726551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans.
    Hara M; Han M
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3333-7. PubMed ID: 7536929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant farnesyltransferase can restore yeast Ras signaling and mating.
    Yalovsky S; Trueblood CE; Callan KL; Narita JO; Jenkins SM; Rine J; Gruissem W
    Mol Cell Biol; 1997 Apr; 17(4):1986-94. PubMed ID: 9121446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics.
    Koblan KS; Kohl NE; Omer CA; Anthony NJ; Conner MW; deSolms SJ; Williams TM; Graham SL; Hartman GD; Oliff A; Gibbs JB
    Biochem Soc Trans; 1996 Aug; 24(3):688-92. PubMed ID: 8878827
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein prenyltransferases.
    Casey PJ; Seabra MC
    J Biol Chem; 1996 Mar; 271(10):5289-92. PubMed ID: 8621375
    [No Abstract]   [Full Text] [Related]  

  • 15. Substrate characterization of the Saccharomyces cerevisiae protein farnesyltransferase and type-I protein geranylgeranyltransferase.
    Caplin BE; Hettich LA; Marshall MS
    Biochim Biophys Acta; 1994 Mar; 1205(1):39-48. PubMed ID: 8142482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified yeast protein farnesyltransferase is structurally and functionally similar to its mammalian counterpart.
    Gomez R; Goodman LE; Tripathy SK; O'Rourke E; Manne V; Tamanoi F
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):25-31. PubMed ID: 8424764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
    Cox AD; Der CJ
    Biochim Biophys Acta; 1997 Aug; 1333(1):F51-71. PubMed ID: 9294018
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutants of Saccharomyces cerevisiae defective in the farnesylation of Ras proteins.
    Goodman LE; Judd SR; Farnsworth CC; Powers S; Gelb MH; Glomset JA; Tamanoi F
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9665-9. PubMed ID: 2124698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growth.
    Omer CA; Anthony NJ; Buser-Doepner CA; Burkhardt AL; deSolms SJ; Dinsmore CJ; Gibbs JB; Hartman GD; Koblan KS; Lobell RB; Oliff A; Williams TM; Kohl NE
    Biofactors; 1997; 6(3):359-66. PubMed ID: 9288406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudodipeptide inhibitors of protein farnesyltransferase.
    deSolms SJ; Deana AA; Giuliani EA; Graham SL; Kohl NE; Mosser SD; Oliff AI; Pompliano DL; Rands E; Scholz TH
    J Med Chem; 1995 Sep; 38(20):3967-71. PubMed ID: 7562930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.